GrowBLOX Sciences Executes Cannabis Supply Agreement With Provisionally-Licensed Medical Pot Dispensary

GrowBLOX Sciences, Inc., “GB Sciences” (GBLX), a company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize safe and consistent medicinal cannabis via their proprietary technologies, is pleased to announce its GB Sciences Nevada has executed a cannabis supply agreement with LVMC, LLC of Clark County, Nevada. LVMC, LLC has committed to purchase not less than twenty percent of LVMC’s inventory requirements from GB Sciences. In addition they have granted interior space to their retail facility for GB Sciences Micro Apothecary.

GrowBlox Sciences CEO Craig Ellins said, “We are excited this group shares our vision for pre-packaged, quality tested, pesticide free and consistent high-value products. We are looking forward to partnering with an organization with the same mission dedicated to the betterment of our military veterans.”

GrowBlox Sciences CFO Cathryn Kennedy reiterated, “This agreement requires us to allocate a certain percentage of our production to be dedicated to LVMC. This is exciting because this will now enable us to expedite by six months our phase two build-out.”

About GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc. “GB Sciences” is a biopharmaceutical research and development company that merges state-of-the-art technologies in plant biology, cultivation technology and post-production processes in order to optimize our safe and consistent medicinal cannabis. The company is pioneering technology, industry-leading processes, and a big data-driven clinical research and development algorithm to bring relief to patients in communities across the country.

To learn more about GB Sciences, Inc., go to www.gbsciences.com.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information
Hayden IR
hart@haydenir.com
917-658-7878

Posted in: Press

Comments are closed.